Genetics of lipoprotein disorders (Q77452737)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785051%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Genetics of lipoprotein disorders (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785051%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

J Davignon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785051%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Genest

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785051%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785051%20AND%20SRC:MED&resulttype=core&format=json

Endocrinology and Metabolism Clinics of North America

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785051%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785051%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785051%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

521-550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785051%20AND%20SRC:MED&resulttype=core&format=json

A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism. Kinetics of apolipoprotein B during placebo and pravastatin therapy

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Is familial combined hyperlipidaemia a genetic disorder of adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Plasma triglyceride and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genetic epidemiology of low-density lipoprotein subclass phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Detection and characterization of the heterozygote state for lipoprotein lipase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Glomerular lipid deposition and proteinuria in a patient with familial dysbetalipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

High density lipoproteins and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Influence of genetic variability in the nondeletion LDL-receptor allele on phenotypic variation in French-Canadian familial hypercholesterolemia heterozygotes sharing a 'null' LDL-receptor gene defect

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lp(a) concentration and apo(a) isoform size. Relation to the presence of coronary artery disease in familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low‐density lipoprotein heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

What benefit can be derived from treating normocholesterolemic patients with coronary artery disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Myocardial infarction in the familial forms of hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Apoproteins B and A-I and coronary artery disease in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Impaired chylomicron remnant clearance in familial combined hyperlipidemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Mapping a gene for combined hyperlipidaemia in a mutant mouse strain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Modulation of Lipoprotein B Binding to the LDL Receptor by Exogenous Lipids and Apolipoproteins CI, CII, CIII, and E

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (RE

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Plasma lipoproteins in familial hepatic lipase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial combined hyperlipidaemia: Use of stable isotopes to demonstrate overproduction of very low‐density lipoprotein apolipoprotein B by the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Apolipoprotein E polymorphism association with lipoprotein profile in endogenous hypertriglyceridemia and familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

A Phenocopy of Type III Dysbetalipoproteinemia Occurring in a Candidate Family for a Putative Apo E Receptor Defect

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Apolipoprotein E polymorphism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Interaction of two lipid disorders in a large French-Canadian kindred.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial hypercholesterolemia in French-Canadians: taking advantage of the presence of a "founder effect".

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The redox status of coenzyme Q10 in total LDL as an indicator of in vivo oxidative modification. Studies on subjects with familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Prevalence and association of atherosclerosis at three different arterial sites in patients with type III hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genetics of type III hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Fat transport in lipoproteins--an integrated approach to mechanisms and disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Absence of familial defective apolipoprotein B-100 in Israeli patients with dominantly inherited hypercholesterolemia and in offspring with parental history of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The affinity of low-density lipoproteins and of very-low-density lipoprotein remnants for the low-density lipoprotein receptor in homozygous familial defective apolipoprotein B-100

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Fasting Triglycerides, High-Density Lipoprotein, and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial hypoalphalipoproteinemia in premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial lipoprotein disorders in patients with premature coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Pseudo type III dyslipoproteinemia is associated with normal fibroblast lipoprotein receptor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Metabolism of apolipoprotein B in members of a family with accelerated atherosclerosis: influence of apolipoprotein E-3/E-2 pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Phenotypic variation in patients heterozygous for familial defective apolipoprotein B (FDB) in three European countries

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Multiple Genetic Determinants of Variation of Plasma Lipoproteins in Alberta Hutterites

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Molecular basis and allele specific screening of apolipoprotein CIISt. Michael

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

No evidence for linkage between familial hypertriglyceridemia and apolipoprotein B, apolipoprotein C-III or lipoprotein lipase genes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

beta-Sitosterolemia with generalized eruptive xanthomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The lipoprotein lipase (Asn291-->Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Apolipoprotein E1-Hammersmith (Lys146-->Asn;Arg147-->Trp), due to a dinucleotide substitution, is associated with early manifestation of dominant type III hyperlipoproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genetic testing for familial hypercholesterolaemia: practical and ethical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Heterogeneity of lipoprotein (a): growing complexities.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Phenotypic expression and frequency of familial defective apolipoprotein B-100 in Belgian hypercholesterolemics.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lipoprotein(a) in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Elevated serum lipoprotein(a) in subclinical hypothyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Type III Hyperlipoproteinemia: Paradoxical Hypolipidemic Response to Estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Phytosterolemia and pseudohomozygous type II hypercholesterolemia in two Chinese patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Phytosterolaemia in a Norwegian family: diagnosis and characterization of the first Scandinavian case

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Phytosterolaemla: Diagnosis, Characterization and Therapeutical Approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

A missense mutation (Asp250→Asn) in exon 6 of the human lipoprotein lipase gene causes chylomicronemia in patients of different ancestries

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

A major locus influencing plasma high-density lipoprotein cholesterol levels in the San Antonio Family Heart Study. Segregation and linkage analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lipoprotein (a) and coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Dominant expression of type III hyperlipoproteinemia. Pathophysiological insights derived from the structural and kinetic characteristics of ApoE-1 (Lys146-->Glu)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lipoprotein glomerulopathy: a pediatric case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Isolated low HDL-cholesterol as an important risk factor for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Differences in the Phenotypic Characteristics of Subjects With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Apolipoprotein A-I deficiency. Biochemical and metabolic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Decreased cholesterol biosynthesis in sitosterolemia with xanthomatosis: diminished mononuclear leukocyte 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and enzyme protein associated with increased low-density lipoprotein receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Family study of serum lipids and lipoproteins in coronary heart-disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Immunohistochemical analysis of spinal intradural xanthomatosis developed in a patient with phytosterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Postprandial hemorrheology and apolipoprotein B metabolism in patients with familial hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genotype at a major locus with large effects on apolipoprotein B levels predicts familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

No evidence of linkage between familial combined hyperlipidemia and genes encoding lipolytic enzymes in Finnish families

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Chylomicron retention disease: exclusion of apolipoprotein B gene defects and detection of mRNA editing in an affected family

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Elevated Lp(a) is the most frequent familial lipoprotein disorder leading to premature myocardial infarction in a country with low cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Phenotype expression in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The role of apolipoprotein E genetic variants in lipoprotein disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genetic evidence from 7 families that the apolipoprotein B gene is not involved in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Adipose Tissue Lipoprotein Lipase and Hormone-Sensitive Lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

HDL-mediated efflux of intracellular cholesterol is impaired in fibroblasts from Tangier disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lipoprotein glomerulopathy. Report of a normolipidemic case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Biochemical Abnormalities in Cerebrotendinous Xanthomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Evidence for a cholesterol-lowering gene in a French-Canadian kindred with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial apolipoprotein E deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Homozygous familial defective apolipoprotein B-100. Enhanced removal of apolipoprotein E-containing VLDLs and decreased production of LDLs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Novel members of the low density lipoprotein receptor superfamily and their potential roles in lipid metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The hypobetalipoproteinemias

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial defective apolipoprotein B-100. Comparison with familial hypercholesterolemia in 18 cases detected in Munich

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Homozygous Tangier disease and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Gemfibrozil and mediterranean diet for patients with high plasma levels of lipoprotein [Lp(a)] and cholesterol?Pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genetics and molecular biology: Editorial overview

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Substrate delivery as a determinant of hepatic apoB secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lipoprotein (a) in thyroid dysfunction before and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The low HDL cholesterol/high triglyceride trait

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Conjoint high triglycerides and low HDL cholesterol across generations. Analysis of proband hypertriglyceridemia and lipid/lipoprotein disorders in first-degree family members

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Decreased resistance against in vitro oxidation of LDL from patients with familial defective apolipoprotein B-100.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The mysteries of lipoprotein(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Atypical xanthomatosis in apolipoprotein E-deficient mice after cholesterol feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Normocholesterolemic tendon xanthomatosis with overproduction of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Genetic influences on lipoprotein(a) concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

The high density lipoprotein- and apolipoprotein A-I-induced mobilization of cellular cholesterol is impaired in fibroblasts from Tangier disease subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Uptake of Type III Hypertriglyceridemic VLDL by Macrophages Is Enhanced by Oxidation, Especially After Remnant Formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Increased serum remnant lipoproteins in patients with apolipoprotein E7 (apo E Suita)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Serum complement and familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Identification and characterization of truncated forms of apolipoprotein B in hypobetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Prevention of raised low-density lipoprotein cholesterol in a patient with familial hypercholesterolaemia and lipoprotein lipase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

Lipoprotein glomerulopathy: first report in a Chinese male

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970024-4

7 January 2021

10.1016/S0889-8529(05)70024-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9785051%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference